First and Only Immuno-Oncology Treatment, Imfinzi® (durvalumab), for Stage III, Unresectable Non-Small Cell Lung Cancer Now Approved in Canada
WTOL,
SOURCE AstraZeneca Patients receiving Imfinzi in the PACIFIC clinical trial lived for nearly one year without their disease…